PM
Proteome Sciences plc
PMSNF · OTC
$0.01 +25.00% (+$0.00)
1M -10.40%
Market Cap £2.16M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
20.0% downside
Current Price
$0.013
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PMSNF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.58x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 21.18%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 26.81%
Net margin 81.50%
Op. margin 69.89%
Quality
8 /100
Poor ROIC 33.74%
ROA 37.08%
Asset turnover 0.45x
Debt
0 /100
High Current ratio 0.13x
Int. coverage -2.84x
Debt/Equity N/A
Stability
22 /100
Unstable Beta 0.15x
Rev. volatility 15.42%
EPS volatility 162.60%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PMSNF
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Anil Wadhwani
Employees
32
Headquarters
Cobham